SCHEMBL26322957

SCHEMBL26322957

Nc1ccc2c(c1)CN(c1cccc(Oc3ccncc3)c1)C2=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 4/20 0.46
CYP11B1 P15538 3/20 0.46
CYP2D6 P10635 1/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
ALDH1A1 P00352 3/20 0.38
MEN1 O00255 1/20 0.38
MITF O75030 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
GFER P55789 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NLRP1 Q9C000 1/20 0.38
NOD2 Q9HC29 1/20 0.38
ATM Q13315 1/20 0.38
FFAR4 Q5NUL3 2/20 0.38
FFAR1 O14842 1/20 0.38
PIK3CG P48736 2/20 0.37
PKM P14618 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24003947 0.80 CYP11B2 (0.46) CYP11B2CYP11B1CYP2D6NPC1RAB9A
SCHEMBL24003929 0.78 CYP11B2 (0.39) CYP11B2CYP11B1NPC1RAB9APIK3CG
SCHEMBL25827086 0.77 CYP11B2 (0.39) CYP11B2CYP11B1NPC1RAB9AFFAR4
SCHEMBL26322920 0.77 MAPK14 (0.53) CYP11B2CYP11B1CYP2D6NPC1RAB9A
SCHEMBL29985044 0.77 UGCG (0.43) CYP11B2CYP11B1NPC1RAB9AFFAR4
SCHEMBL26328176 0.76 CYP11B2 (0.37) CYP11B2CYP11B1NPC1RAB9AMAPT
SCHEMBL14259445 0.76 NPC1 (0.67) CYP11B2CYP11B1CYP2D6NPC1RAB9A
SCHEMBL25820789 0.74 NPC1 (0.41) CYP11B2CYP11B1CYP2D6NPC1RAB9A
SCHEMBL19967147 0.74 CYP11B2 (0.58) CYP11B2CYP11B1NPC1RAB9AFFAR4
SCHEMBL24010356 0.72 MAPK13 (0.38) CYP11B2NPC1RAB9AGAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295114-A1 AKT3 MODULATORS Georgiamune Inc. 2023-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295114-A1 AKT3 MODULATORS AKT3, AKT2, MTOR CYP11B2 860/4885CYP11B1 751/4885CYP2D6 3871/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.